C80Homo sapiens (Human)Cancer cell line
No AI-generated summary available for this cell line.
Basic Information
Database ID | CVCL_5249 |
---|---|
Species | Homo sapiens (Human) |
Tissue Source | Rectum[UBERON:UBERON_0001052] |
Donor Information
Age | 69 |
---|---|
Age Category | Adult |
Sex | Male |
Disease Information
Disease | Rectal adenocarcinoma |
---|---|
Lineage | Bowel |
Subtype | Rectal Adenocarcinoma |
OncoTree Code | READ |
DepMap Information
Source Type | ECACC |
---|---|
Source ID | ACH-001459_source |
Known Sequence Variations
Type | Gene/Protein | Description | Zygosity | Note | Source |
---|---|---|---|---|---|
MutationSimple | TP53 | p.Gln52Ter (c.154C>T) | Unspecified | - | PubMed=16418264 |
MutationSimple | SMAD4 | p.Asp351His (c.1051G>C) | Homozygous | - | from parent cell line Caco-2 |
MutationSimple | KRAS | p.Ala146Val (c.437C>T) | Unspecified | - | PubMed=20570890 |
MutationSimple | APC | p.Leu629Ter (c.1886T>G) | Unspecified | - | PubMed=24755471 |
Haplotype Information (STR Profile)
Short Tandem Repeat (STR) profile for cell line authentication.
Loading gene expression data...
Publications
Pharmacoproteomic characterisation of human colon and rectal cancer.
Weichert W., Knapp S., Feller S.M., Kuster B.
Mol. Syst. Biol. 13:951-951(2017).
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets.
Linnebacher M., Cordero F., Di Nicolantonio F., Bardelli A.
Nat. Commun. 6:7002.1-7002.10(2015).
Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer.
Mariadason J.M., Sieber O.M.
Cancer Res. 74:3238-3247(2014).
Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines.
Orphanides G., French T., Wessels L.F.A.
BMC Med. Genomics 5:66.1-66.15(2012).
5-fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency.
Bracht K., Nicholls A.M., Liu Y., Bodmer W.F.
Br. J. Cancer 103:340-346(2010).
Genomic and biological characterization of exon 4 KRAS mutations in human cancer.
Lash A., Ladanyi M., Saltz L.B., Heguy A., Paty P.B., Solit D.B.
Cancer Res. 70:5901-5911(2010).
Cell growth, global phosphotyrosine elevation, and c-Met phosphorylation through Src family kinases in colorectal cancer cells.
Emaduddin M., Bicknell D.C., Bodmer W.F., Feller S.M.
Proc. Natl. Acad. Sci. U.S.A. 105:2358-2362(2008).
Analysis of p53 mutations and their expression in 56 colorectal cancer cell lines.
Liu Y., Bodmer W.F.
Proc. Natl. Acad. Sci. U.S.A. 103:976-981(2006).
APC mutations in sporadic colorectal tumors: a mutational 'hotspot' and interdependence of the 'two hits'.
Papadopoulou A., Bicknell D.C., Bodmer W.F., Tomlinson I.P.M.
Proc. Natl. Acad. Sci. U.S.A. 97:3352-3357(2000).
Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells.
Pignatelli M., Bodmer W.F.
Proc. Natl. Acad. Sci. U.S.A. 96:2316-2321(1999).